Chemotherapy for lymphatic filariasis: progress but not perfection

References

• World Health Organisation. Building partnerships for lymphatic filariasis: strategic plan. World Health Organisation, Geneva, Switzerland (1999).
   Google Scholar
• Melrose WD. Lymphatic filariasis — new insights into an old disease Int. J. Parasitot 32, 947–960 (2002).
   PubMed Web of Science ®Google Scholar
• •A concise overview of the history, biology, epidemiology, diagnosis and control of lymphatic filariasis with a large number of references.
   Google Scholar
• Cox FEG. Elimination of lymphatic filariasis as a public health problem. Parasitot Today 16, 135 (2000).
   PubMedGoogle Scholar
• Mobmeux DH, Zagaria N. Lymphatic filariasis elimination: progress in global programme development. Ann. Trap. Med Parasitot 96(Suppl.), S15—S40 (2002).
   Google Scholar
• James DM, Gillies HM. In: Human Antiparasite Drugs: Pharmacology and Usage. John Wiley and Sons, Brisbane, Australia (1985).
   Google Scholar
• MacKenzie CD, Kron MA. Diethylcarbamazine: a review of its action in oncocerciasis, lymphatic filariasis and inflammation. Trap. Dis. Bull. 82, R1—R36 (1985).
   Google Scholar
• Campbell WC, Rew RS. Chemotherapy of Parasitic Diseases. Plenum Press, NY, USA (1986).
   Google Scholar
• Maizels RM, Denham DA. Diethylcarbamazine (DEC): immuno pharmacological interactions if an antifilarial drug. Parasitot 105 (Suppl.), S49—S60 (1992).
   Google Scholar
• •A very good article on the pharmacology and anti-parasite action of DEC with references to earlier work
   Google Scholar
• Bhaffacharya C, Singh RN, Misra S. Rathaur S. Diethylcarbamazine: effect on lysosomal enzymes and acetylcholine in Wuchereria Bancrofiian infection. Trop. Med Int. Health. 2, 686–690 (1997).
   PubMed Web of Science ®Google Scholar
• Taylor MJ, Cross HE, Mohammed AA, Trees AJ, Bianco AE. Susceptibility of Brugia malayi and Orzcocerca lienalis microfilariae to nitric oxide and hydrogen peroxide in cell free culture and from IFN y-activated macrophages. Parasitol. 112, 315–322 (1996).
   PubMed Web of Science ®Google Scholar
• Winkler S, El Menyawi, Floris-Linnau K, Graninger W Short report: total serum levels of the nitric oxide derivatives nitrite/nitrate during microfilarial clearance in human filarial disease. Am. J. Trap. Med. Hyg. 59,523–525 (1998).
   Google Scholar
• Well GJ, Sethumadhavan KVP, Santhanam S, Jain DC, Ghosh TK Persistence of parasite antigenaemia following diethylcarbamazine therapy of Bancrofiian filariasis. Am. J. Trap. Med. Hyg. 38, 589–595 (1988).
   Google Scholar
• Figueredo-Silva, Jungman P Noroes J, et al Histologicaly evidence for adulticidal effect of low doses of diethylcarbamazine in Bancroftian filariasis. Trans. R. Soc. Trap. Med. Hyg. 90,192–194 (1996).
   PubMed Web of Science ®Google Scholar
• Ismail MM, Weil GJ, Jayasinghe KS, et al Prolonged clearance of microfilaraemia in patients with Bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine. Trans. R. Soc. Trap. Med. Hyg. 90,684–688 (1996).
   Google Scholar
• Eberhard ML, Hightower AW, Addiss G, Lammie MJ. Clearance of Wuchereria bancrofii antigen after treatment with diethylcarbamazine or ivermectin. Am. J. Trap Med. Hyg. 57, 483–486 (1997).
   Google Scholar
• Wijers DJB. Bancroftian filariasis in Kenya V: mass treatment given by members of the local community. Ann Trop Med. Parasitol. 78,383–394 (1984).
   PubMed Web of Science ®Google Scholar
• Mataika JU, Mmura E, Koroivueta J, Shimada M. Efficacy of five annual single doses of diethylcarbamazine for treatment of lymphatic filariasis in Fiji. Bulletin ofthe World Health Oganisatiorz. 76,557–579 (1998).
   Web of Science ®Google Scholar
• Taylor MJ, Turner PE Control of lymphatic filariasis. Parasitol Today 13, 85–86 (1997).
   Google Scholar
• Jing-yuan L, Xin-ji L, Zi C, et al Filariasis and its control in Fujian, China. Southeast Asian J. Trop. Med. Public Health 22, 147–154 (1991).
   PubMedGoogle Scholar
• Jing-yuan L, Zi C, Xiao-hong H, Zhao-ping T Mass treatment of filariasis using DEC-medicated salt./ Trap. Med. Hyg. 95, 132–135 (1992).
   PubMed Web of Science ®Google Scholar
• Liu JY, Chen Z, Huang JH, Tu SP Mass treatment of filariasis using DEC-medicated salt. J. Trap. Med. Hyg. 95, 132–135 (1992).
   PubMed Web of Science ®Google Scholar
• Krishnarao P, Kaur R, Ghosh TK Long-term effect of diethylcarbamazine medicated common salt on bancrofiian filariasis. J. Comm. Dis. 23,128–130 (1991).
   Google Scholar
• Michael E, Meyrowitsch DW SimonsenPE. Cost and cost effectiveness of mass diethylcarbamizine chemotherapy for the control of Bancrofiian filariasis: comparison of four strategies in Tanzania. Trap. Med. Int. Health. 1,414 426 (1996).
   Web of Science ®Google Scholar
• Meyrowitsch D, Simonsen PE. Long-term effect of mass diethylcarbamazine chemotherapy on bancrofiian filariasis: results at four years after start of treatment. Trans. R Soc. Trap. Med. Hyg. 92,98–103 (1998).
   Google Scholar
• Shenoy RK, Varghese J, Kuttikkal VV The efficacy, tolerability and safety of diethylcarbamizine-fortified salt in the treatment of the microfilaraemias of brugian filariasis: an open, hospital based study. Ann. Tropical Med. Parasitol. 92, 285–293 (1998).
   PubMed Web of Science ®Google Scholar
• Forsyth K New approaches to the control of lymphatic filariasis using diethylcarbamazine. PNG. Med. J. 30, 189–191 (1987).
   PubMedGoogle Scholar
• Parton F, Purnomo A, Oemijati S, Soewarta A. The long-term effects of repeated diethylcarbamazine administration with special reference to microfilaraemia and elephantiasis. Acta. Trap. 38,217–225 (1984).
   Google Scholar
• Parton° F, Maizels RM, Puromo S. Towards a filarial-free community: evaluation of filariasis control over an eleven year period in Flores, Indonesia. Trans. R. Soc. Trap. Med Hyg. 83,821–826 (1989).
   Google Scholar
• Panicker KN, Krishnamoorthy K, Sabesan S, Prathiba J, Abidha K Comparison of effects of mass annual and biannual single dose therapy with diethylcarbamazine for the control of Mzlyan filariasis. SE Asian J. Trap. Med. Public Health 22,402–411 (1991).
   Google Scholar
• Kimura E, Penania L, Spears GE The efficacy of annual doses of iethylcarbamazine citrate against diurnally sub-periodic Bancrofiian filariasis in Samoa. Bull WHO 63,1097–1106 (1985).
   PubMed Web of Science ®Google Scholar
• Hawking F, Sewell P Thurston JP. The mode of action of hetrazan on filarial worms. Br. J. Pharmacol. 5,217–238 (1950).
   PubMed Web of Science ®Google Scholar
• Zheng HJ, Tao ZH, Cheng WF, et al Efficacy of ivermectin for control of microfilaraemia re rring after treatment with diethylcarbamazine. 2. Immunologic changes following treatment. Am. J. Trap. Med Hyg. 45,175–181 (1991).
   Google Scholar
• Thong-Mng L, Thong-Jun S. A field survey on the role of low-density microfilaraemia cases in the transmission of filariasis. SE Asian J. Trap. Med. Public Health 20, 153–156 (1989).
   PubMedGoogle Scholar
• Eberhard ML, Dickinson CM, Hightower AW, Lammie MJ. Bancrofiian filariasis: long-term effects of treatment with diethylcarbamizine in a Haitian population. Am. J. Trop. 114.d H. 45,728-733(1991).
   Google Scholar
• Campbell WC (Ed.), Springer-Verlag, NY, USA (1989).
   Google Scholar
• Goa KL, McTavish D, Qissold SE Ivermectin: a review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs 42,640–648 (1991).
   PubMed Web of Science ®Google Scholar
• Kumaraswami V, Ottesen EA, VijayasekaranV Ivermectin for the treatment of Wuchereria bancrofii fdariasis:efficacy and adverse reactions. JAMA 259,3150–3153 (1988).
   PubMed Web of Science ®Google Scholar
• Ottesen EA, Campbell WC Ivermectin in human medicine./ AntimicrobiaL Chem. 34, 195–203 (1994).
   PubMed Web of Science ®Google Scholar
• Ottesen EA, Ramachandran CE Lymphatic filariasis infection and disease: control strategies. PantsitoL Today 11, 129–131 (1995).
   Google Scholar
• Zheng HJ, Piessens WF, Tao ZH, et al Efficacy of ivermectin for control of microfilaraemia recurring after treatment with diethylcarbamazine. I. Clinical and parasitological observations. Am. J. Trap. Med. Hyg 45,168–174 (1991).
   Google Scholar
• Addiss DG, Eberhard ML, Lammie PL Comparative efficiency of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofii microfilaraemia. Am. J. Trap. Med Hyg. 48,178–185 (1993).
   Google Scholar
• Kazura J, Greenberg J, Perry R, Well G, Day K, Alpers M. Comparison of single-dose diethylcarbamazine and ivermectin for the treatment of Bancrofiian filariasis in Papua New Guinea. Am. J. Trap. Med. Hyg. 49,804–811 (1993).
   Google Scholar
• Moulia-Pelat JP, Nguyen LN, Glaziou P. Chanteau S, Gay VM, Martin PMV, Cartel JL. Safety trial of single-dose treatments with a combination of ivermectin and diethylcarbamazine in Bancroftian filariasis. Trap. Med. Parasitol. 44,79-82 (1993).
   Google Scholar
• Nguyen NL, Moulia-Pelat JP, Cartel JL Control of lymphatic filariasis in an endemic area of Polynesia by ivermectin 400 micrograms/kg. Trans. R Soc. Trap. Med. Hyg: 90,689-691(1996).
   Google Scholar
• Small MM, Well GJ, Jayasinghe KS, et al Prolonged clearance of microfilaraemia in patients with Bancroftian filariasis after multiple high doses of ivermectin of diethylcarbamazine. Trans. R Soc. Trap. Med Hyg. 90, 684–688 (1996).
   Google Scholar
• Dreyer G, Amaral F, Noroes J, Nen A, Medeiros Z, Coutinho A, Addiss D. Direct assesment of the adulticidal efficicncy of a single dose of ivermectin in lymphatic filariasis. Trans. R. Soc. Trap. Med. Hyg. 89, 441–443 (1995).
   Google Scholar
• Dreyer G, Noroes J, Amaral F, Medeiros Z, Addiss D. A new tool to assess the adulticidal efficacy in vivo of antifilarial drugs for Bancrofiian filariasis. Trans. R. Soc. Trap. Med. Hyg. 89, 225–226 (1995).
   PubMed Web of Science ®Google Scholar
• Dreyer G, Addiss D, Noroes J, Amaral F, Rocha A, Coutinho A. Ultrasonic assessment of the adulticidal efficacy of repeat high-dose ivermectin in Bancroftian filariasis. Trap. Med. Int. Health. 1, 427–432 (1996).
   Web of Science ®Google Scholar
• Lacey E, Brady RL, Pritchard RK, atson TR. Comparison of inhibition of polymerase of mammalian tubulin: helminth ovicidal activity by benzimidazole carbamates. Vet. Parasitol. 23, 105–119 (1987).
   PubMed Web of Science ®Google Scholar
• Oxberry ME, Geary TG, Winterrowd CA, Pritchard RK Individual expression of recombinant a-and B-tuberlin from Haemonchus contortus: polymerization and drug effects. Protein Expr. Puri f 21, 30–39 (2001).
   PubMed Web of Science ®Google Scholar
• Horton J. Albendazole: a broad spectrum anthelminthic for the treatment of individuals and populations. Curr. Opin. Infect. Dis. 15, 599–608 (2002).
   PubMed Web of Science ®Google Scholar
• Ottesen EA, Ismail MM, Horton J. The role of Albendazole in programmes to eliminate lymphatic filariasis. Parasitol. Today 15, 382–386 (1999).
   PubMedGoogle Scholar
• Moulia-Pelat JP, Nguyen LN, Glaziou P, et al Safety trial of single-dose treatments with a combination of ivermectin and diethylcarbamazine in Bancroftian filariasis. Trap. Med. Parasitol. 44, 79–82 (1993).
   PubMedGoogle Scholar
• Moulia-Pelat JPP. Chanteau S, Glaziou , et al Periodicity of Wuchereria bancrofii var Pacifica filariasis in French Polynesia. Trap. Med. Parasitol. 44, 83–85 (1993).
   PubMedGoogle Scholar
• Moulia-Pelat JP, Nguyen LN, Glaziou P, et al Ivermectin 400 jig/kg long-term suppression of microfilaraemia in Bancroftian filariasis. Trans. R. Soc. Trap. Med. Hyg. 88, 107–109 (1994).
   Google Scholar
• Moulia-Pelat JP, Nguyen LN, Glaziou P, et al Ivermectin plus diethylcarbamazine: an additive effect on early microfilariae clearance. Am. J. Trap. Med. Hyg. 50, 206–209 (1994)
   Google Scholar
• Moulia-Pelat JP, Glaziou PH, Well GJ, Nguyen LN, Gaxotte PH, Nicolas L. Combination ivermectin plus diethylcarbamazine, a new effective tool for control of lymphatic filariasis. Trap. Med. ParasitoL 46, 9–12 (1995).
   PubMedGoogle Scholar
• Nicolas L, Plichart C, Nguyen NL, Moulia-Pelat JP. Reduction of Wuchereria bancrofii adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. J. Infect. Dis. 175, 489–492 (1997).
   PubMed Web of Science ®Google Scholar
• Addiss DG, Beach MJ, Streit TG, et al Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrvfii miciofilaraemia in Haitian children. Lancet 350, 480–484(1997).
   PubMed Web of Science ®Google Scholar
• Ismail MM, Premaratne UN, Abeyewickreme W Treatment of Bancroftian filariasis with ivermectin in Sri Lanka: evaluation of efficacy and adverse reactions. Trap Biomed. 8, 71–75 (1991).
   Google Scholar
• Ismail MM, Well GJ, Jayasinghe KS, et al Prolonged clearance of microfilaraemia in patients with Bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine. Trans. R. Soc. Trap. Med. Hyg. 90, 684–688 (1996).
   Google Scholar
• Ismail MM, Jayakody RL, Weil GJ, et al Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of Bancroftian filariasis. Trans. R. Soc. Trap. Med. Hyg. 92, 94–97 (1998).
   Google Scholar
• ••An excellent research paper on the efficacyof the drugs and combinations used in the global elimination program.
   Google Scholar
• Training module on lymphatic filariasis or drug distributors in non-onchocerciasis co-endemic countries. WHO (2000).
   Google Scholar
• The programme to eliminate lymphatic filariasis. Essential elements for medical personnel in onchocerciasis co-endemic countries. WHO (2000).
   Google Scholar
• Dreyer G, Addiss D, Roberts J, Noroes J. Progression of lymphatic vessel dilation in the presence of living Wuchereria bancrofii. Trans. R. Sco. Trap. Med. Hyg. 96, 157–161 (2002).
   PubMed Web of Science ®Google Scholar
• ••The authors provide compelling evidenceas to why an effective tnarofilaricide is required.
   Google Scholar
• Lazdins J, Kron M. New molecular targets for filariasis drug discovery. Parasitol. Today 15, 305–306 (1999).
   PubMedGoogle Scholar
• Mak JW, Navaratnam V. Ramachandran CP. Experimental chemotherapy of lymphatic filariasis. A review. Ann. Trap. Med. Parasitol. 85, 131–137 (1991).
   PubMed Web of Science ®Google Scholar
• Gayral PPM, Bodes C, BrienneMJ, Leclercq M, Jacques J. Loiseau. In vitro and in vivo antifilarial activity of ethynesulfonamides, epoxyethanesulfonamides and carboxamide analogues. Arzneimitteffbrschung 45, 1122–1127 (1995).
   PubMed Web of Science ®Google Scholar
• Loiseau PM, Depremc P. In vitro antifilarialevaluation of phenoxycyclohexane derivatives. Ann. Trap. Med. ParasitoL 87, 469–476 (1993).
   PubMed Web of Science ®Google Scholar
• Srivastava SK, Agarwal A, Chauhan PM, Agarwal SK, Bhaduri AP, Singh SN, Fatima N, Chatterjee RK. Potent 1,3-substituted-9H-pyridol [3,4-B] indoles as new lead compounds in antifilarial chemotherapy. Bioorgan. Med. Chem. 7, 1223–1236 (1999).
   PubMed Web of Science ®Google Scholar
• Sundberg RJ, Biswas S, Kumar Murthi K, Rowe D, McCall JW, Dzimianski MT Bis-cationic hetero aromatics as macrofilaricides: synthesis of bis-amidine and bis-guanylhydrazone derivatives of substituted imidazo[1,2-A]pyridines. Med. Chem. 41, 4317–432 (1998).
   Web of Science ®Google Scholar
• Varma Rajendra S, Sarin S, Chatterjee RK Synthesis of beta-amino substituted 4-amino-3-nitropropiophenones as diethylcarbamazine analogs and their antifilarial activity. Ind. J. Chem. 31, 711–713 (1992).
   Google Scholar
• Sivan VM, Rai RK Quinone analogue irrecoverably paralyses the filarial parasites in vitro. Biochem. Biophys Res. Commun. 256, 81–83.
   PubMedGoogle Scholar
• Monzon RB. Traditional medicine in the treatment of parasitic diseases in the Philippines. Southeast Asian J. Trap. Med. Public Health 26, 421–428 (1995).
   Google Scholar
• Dutta A, Sukul N. Filariacidal properties of a wild herb Arzdrographis paniculata. Helminthol. 56, 81–84 (1982).
   PubMed Web of Science ®Google Scholar
• Dutta A, Sukul N. Antifilarial effect of Zingiber officinale on Dirofilaria immitis. HelminthoL 61, 268–270 (1987).
   PubMed Web of Science ®Google Scholar
• Singh SN, Bhatnagar S, Fatma N, ChauhanPMS, Chatterjee RK Antifilarial activity of a synthetic marine alkaloid, aplysinopsin (CDRI compound 92/138). Trap. Med. Int. Health 2, 535–543 (1997).
   PubMed Web of Science ®Google Scholar
• Loiseau PM, Bourass J, Letoumeux Y. Lymphotrophic antifilarial agents derived from closantel and chlorambucil. Int. I. Parasitol. 27,443–447 (1997).
   Web of Science ®Google Scholar
• Hoerauf A, Nissen-Pahle K, Schmetz C, et al Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility./ Clin. Invest. 103,11–18 (1999).
   Google Scholar
• oerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth I, Fleischer B, Buttner DW. Endosymbiotic bacteria in worms as targets for a novel chemotherapy for filariasis. Lancet 355, 211–213 (2000).
   PubMed Web of Science ®Google Scholar
• Taylor MJ, HoeraufA. Wolbachia bacteria of filarial nematodes. Parasitol Today 15, 437–442 (1999).
   PubMedGoogle Scholar
• Taylor MJ. Wolbachia bacteria of filarial nematodes in the pathogenesis of disease and as a target for control. Trans. R. Soc. Trap. Med. Hyg. 94,596–598 (2000).
   Google Scholar
• Townson H. Wolbachia as a potential toolfor suppressing filarial transmission. Ann. Trap. Med. Parasitol 96(Suppl.), S117—S127 (2002).
   PubMedGoogle Scholar
• Doxycyline as a novel strategy against bancroftian filariasis — depletion of Wolbachia endosymbionts from Wuchereria bancrofii and stop of microfilaria production. Med. Microbial Immunol (Ber). (Epub ahead of print).
   Google Scholar
• ••Provides the first field-based evidence thatthe targeting of Wolbachia is likely to be a worthwhile filariasis control tool.
   Google Scholar
• Control of filarial infections: not the beginning of the end but more research is needed. Curr. Opin. Infect. Dis. 16, 403–410 (2003).
   PubMed Web of Science ®Google Scholar